How a common gum bacterium harms the stem cells that rebuild gums

P. gingivalis Effect on Periodontal Mesenchymal Stem Cell

NIH-funded research Nova Southeastern University · NIH-11141174

This project looks at how the gum bacterium Porphyromonas gingivalis causes stem cells in the gums to die and may explain why gum disease destroys tissue.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNova Southeastern University NIH-funded
Lab location1 site (Fort Lauderdale-Davie, UNITED STATES)
Project IDNIH-11141174 on NIH RePORTER

What this research studies

Scientists will grow human periodontal mesenchymal stem cells in the lab and expose them to the gum pathogen P. gingivalis to see how the cells die. They will measure signs of programmed cell death, release of chromatin material, and the molecular signals involved. The team will compare responses to other bacteria to pinpoint what makes P. gingivalis harmful to these stem cells. Findings will be used to search for ways to prevent stem cell loss and improve gum and bone healing in periodontitis.

Who could benefit from this research

Good fit: People with periodontitis or those willing to donate small gum tissue samples could be the most relevant participants or sample donors for this line of research.

Not a fit: People without gum disease or those whose tissue loss is already beyond biological repair may not directly benefit from this research.

Why it matters

Potential benefit: If successful, this work could point to treatments that protect gum stem cells and help preserve or restore connective tissue and bone in periodontal disease.

How similar studies have performed: Prior studies show P. gingivalis contributes to gum inflammation and damages immune and bone cells, but the idea that it triggers regulated death of gum stem cells is a newer area being explored.

Where this research is happening

Fort Lauderdale-Davie, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.